Well, recently heard about a device called the EarPopper
that can be used by both children and adults. It basically is a device that pops your ear for you, potentially helpful in kids with persistent middle ear fluid and who don't quite understand how to auto-insufflate their ears. It is also helpful even in adults who suffer from eustachian tube dysfunction. In any case, we'll see how effective this device is... Of note, they sell these on Amazon.com...
December 23, 2006
December 21, 2006
News Reports on ENT Topics
We have added a webpage that contains a running news feed from Medical News Today on ENT topics specifically. These news reports are gleaned from throughout the world. Check it out here!
New Audio & Video of Muscle Tension Aphonia After Speech Therapy Posted
Last week, we posted an audio & video sample of a patient who had muscle tension aphonia. Today, we have posted audio & video of the same patient (Example #4) after undergoing self-directed speech therapy. What a difference one week makes!!!
New Audio & Video of Bacterial Laryngitis Posted!
A new stroboscopic video of a patient with bacterial laryngitis has been posted. After hundreds and hundreds of patients I've evaluated for hoarseness, I've finally found one that is a bacterial laryngitis. In my experience, this type of laryngitis is quite uncommon.
December 20, 2006
Potential New Nasal Spray for Patients Suffering from Chronic Sinusitis
This blog is an OPINION and not medical advice. If there are any questions, please see your physician.
Accentia Pharmaceuticals is in the process of testing a new nasal spray called SinuNase which contains the active ingredient Amphotericin B. Why is this medication of interest to an ENT? Well, it would be one potential treatment for patients with chronic rhinosinusitis in which airborne fungus is the underlying cause of persistent sinusitis in spite of adequate antibiotic and surgical treatment.
This medication is currently undergoing Phase III FDA approval.
Accentia Pharmaceuticals is in the process of testing a new nasal spray called SinuNase which contains the active ingredient Amphotericin B. Why is this medication of interest to an ENT? Well, it would be one potential treatment for patients with chronic rhinosinusitis in which airborne fungus is the underlying cause of persistent sinusitis in spite of adequate antibiotic and surgical treatment.
This medication is currently undergoing Phase III FDA approval.
Subscribe to:
Posts (Atom)




